News and Views in the Management of Myasthenia Gravis
News and Views in the Management of Myasthenia GravisNils Erik Gilhus
Sign up to use
News and Views in the Management of Myasthenia Gravis

News and Views in the Management of Myasthenia Gravis

Sign up to use
Sign up to use
Dr. Jeffrey Guptill has received research grants and contracts: from: US NIH, NINDS (K23NS085049, HHSN27100001), NIAID (HHSN272201300017I), Myasthenia Gravis Foundation of America, the Grifols Foundation, the Alzheimer’s Association, Ra Pharmaceuticals. He has also received personal compensation in the past year from Alexion, Kashiv, Argen-X, and Momenta, Inc for consulting services and from Grifols for educational activities.